Market Research Logo

Ophthalmology Drugs Market Global Briefing 2018 Including: Ophthalmology Drugs, Dry Eye Medication, Antiglaucoma DrugsCovering: Novartis AG, F. Hoffmann-La Roche Ltd., Allergan Plc., Valeant Pharmaceuticals Intl Inc., Bayer AG, Santen Pharmaceutical Co.,

Ophthalmology Drugs Market Global Briefing 2018 Including: Ophthalmology Drugs, Dry Eye Medication, Antiglaucoma DrugsCovering: Novartis AG, F. Hoffmann-La Roche Ltd., Allergan Plc., Valeant Pharmaceuticals Intl Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., Gilead, Otsuka Pharmaceutical Co., Ltd., Shire Plc.

North America was the largest region in the ophthalmology drugs market in 2017, accounting for around 30% market share. This was mainly due to the high per capita healthcare expenditure and access to advanced eye care facilities in the region. Western Europe was the second largest region accounting for around 22% market share. Africa was the smallest region accounting for around 3% market share.

Opthalmalogy Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global opthalmalogy drugs sector.

Reasons to Purchase

  • Fully updated for 2018.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Opthalmalogy Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the opthalmalogy drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the opthalmalogy drugs market and suggests approaches.

Scope

Markets Covered: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs.

Companies Mentioned: Novartis AG, F. Hoffmann-La Roche Ltd., Allergan Plc., Valeant Pharmaceuticals Intl Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., Gilead, Otsuka Pharmaceutical Co., Ltd., Shire Plc.

Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Ophthalmology Drugs Market Characteristics
Ophthalmology Drugs Market Historic Growth (2013-17)
Ophthalmology Drugs Market Forecast Growth (2017-21)
Ophthalmology Drugs Market Segmentation
Global Ophthalmology Drugs Market, Split By Segments, 2017, $ Billion
Other Opthalmological Drugs
Antiglaucoma
Dry Eye Medication
Global Ophthalmology Drugs Market, Historic and Forecast, Split By Segments, 2013-2021
Ophthalmology Drugs Market Geography Regional and Country Comparison
Global Ophthalmology Drugs Market, Split By Regions, 2017
Global Ophthalmology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021
Global Ophthalmology Drugs Market, Split By Country, 2017
Global Ophthalmology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Ophthalmology Drugs Market Competitive Landscape
Novartis AG
F. Hoffmann-La Roche Ltd.
Allergan Plc.
Valeant Pharmaceuticals Intl Inc.
Bayer AG
Santen Pharmaceutical Co., Ltd.
Gilead
Otsuka Pharmaceutical Co., Ltd.
Shire Plc.
Novartis AG
F.Hoffmann-La Roche
Allergan
Ophthalmology Drugs Market Key Mergers And Acquisitions
Actavis Plc. Acquired Allergan Inc.
Santen Pharmaceutical Acquired Merck’s Ophthalmology Products
Astellas Pharma Acquired Ocata Therapeutics
Horizon Pharma Acquired River Vision Development Corp.
Sun Pharma Acquired InSite Vision
Novartis Acquired Encore Vision
Purdue Canada Acquired Merck’s Ophthalmology Portfolio
Lupin Acquired Laboratorios Grin
Ophthalmology Drugs Market Trends And Strategies
Rho-Kinase Inhibitors In Glaucoma Treatment
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Dry Eye Treatment
Development Of Combination Therapies
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company
List of Figures
Figure 1: Global Ophthalmology Drugs Market, Historic Market Size, 2013-2017, $ Billion
Figure 2: Global Ophthalmology Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion
Figure 3: Global Ophthalmology Drugs Market, Split By Segments, 2017, $ Billion
Figure 4: Global Ophthalmology Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021
Figure 5: Global Ophthalmology Drugs Market, Split By Region, 2017, $ Billion
Figure 6: Global Ophthalmology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021
Figure 7: Global Ophthalmology Drugs Market, Split By Country, 2017, $ Billion
Figure 8: Global Ophthalmology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Figure 9: Global Ophthalmology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%)
List of Tables
Table 1: Global Ophthalmology Drugs Market, Historic Market Size, 2013-2017, $ Billion
Table 2: Global Ophthalmology Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion
Table 3: Global Ophthalmology Drugs Market, Split By Segments, 2017, $ Billion
Table 4: Global Ophthalmology Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021
Table 5: Global Ophthalmology Drugs Market, Split By Region, 2017, $ Billion
Table 6: Global Ophthalmology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021
Table 7: Global Ophthalmology Drugs Market, Split By Country, 2017, $ Billion
Table 8: Global Ophthalmology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Table 9: Global Ophthalmology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report